跳转至内容
Merck
CN
所有图片(1)

文件

安全信息

ST1568

Sigma-Aldrich

Anti-DEFB4 Mouse mAb (4C4)

liquid, clone 4C4, Calbiochem®

登录查看公司和协议定价

别名:
Anti-Defensin β4
UNSPSC代码:
12352203
NACRES:
NA.41

生物来源

mouse

质量水平

抗体形式

purified antibody

抗体产品类型

primary antibodies

克隆

4C4, monoclonal

形式

liquid

不包含

preservative

种属反应性

human

制造商/商品名称

Calbiochem®

储存条件

OK to freeze
avoid repeated freeze/thaw cycles

同位素/亚型

IgG1

运输

wet ice

储存温度

−20°C

靶向翻译后修饰

unmodified

基因信息

human ... DEFB4A(1673)

一般描述

Purified mouse monoclonal antibody. Recognizes the DEFB4 protein.
Recognizes the DEFB4 protein.
This Anti-DEFB4 Mouse mAb (4C4) is validated for use in ELISA, Immunoblotting for the detection of DEFB4.

免疫原

A recombinant polypeptide corresponding to amino acids 24-65 of human DEFB4, expressed as a GST fusion protein

应用


ELISA (see comments)
Immunoblotting (1-5 g/ml)

警告

Toxicity: Regulatory Review (Z)

外形

In PBS, pH 7.2.

重悬

Following initial thaw, aliquot and freeze (-20°C).

其他说明

For ELISA, this antibody can be used as the capture antibody; recommended concentration is 10 ng/ml, 1 µg/well, 100 µl total volume. Variables associated with assay conditions will dictate the proper working dilution.

法律信息

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

WGK

nwg

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Olivia McGinn et al.
Oncogene, 39(12), 2478-2492 (2020-01-29)
Estrogen receptor (ER) positive breast cancers often contain subpopulations of cells that express the intermediate filament protein cytokeratin 5 (CK5). CK5+ cells are enriched in cancer stem cell (CSC) properties, can be induced by progestins, and predict poor prognosis in
Jessica Finlay-Schultz et al.
Breast cancer research : BCR, 22(1), 68-68 (2020-06-25)
Breast cancer is a highly heterogeneous disease characterized by multiple histologic and molecular subtypes. While a myriad of breast cancer cell lines have been developed over the past 60 years, estrogen receptor alpha (ER)+ disease and some mutations associated with this
L M Fettig et al.
Oncogene, 36(44), 6074-6084 (2017-07-12)
Half of estrogen receptor-positive breast cancers contain a subpopulation of cytokeratin 5 (CK5)-expressing cells that are therapy resistant and exhibit increased cancer stem cell (CSC) properties. We and others have demonstrated that progesterone (P4) increases CK5+ breast cancer cells. We

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门